Fundraising FoxSigrid Therapeutics
4 known investors
Find your way into Sigrid Therapeutics
Sign up to find every way you can get introduced to Sigrid Therapeutics
- Your email: who you already know at Sigrid Therapeutics, and who your contacts know
- 2nd- and 3rd-degree connections: people you know who worked, studied or invested with the Sigrid Therapeutics team
- Your LinkedIn: the connections who can make the intro for you
We rank every route by how warm it is, so you raise on warm intros instead of cold emails.
Sigrid Therapeutics develops non-pharmaceutical solutions for blood sugar control and weight management using its patented SiPore silica technology, which slows the digestion of carbohydrates and fats in the gut. The company offers medical and consumer metabolic health products aimed at people with prediabetes, diabetes, and obesity.
Founders & leadership
SA
Sana AlajmovicCo-founder & CEO
Investors · 4
Joyance Partnerslisted by Joyance PartnersBerlin
How we know: newswire.ca · joyancepartners.com · Not right? Tell us
Ataraxia VCreportedSan Francisco · $50K – $1M
How we know: a partner's Signal profile · Not right? Tell us
Also in the syndicate · 2
Crosslight PartnersIrrus Investments
In the news
Frequently asked questions
- What does Sigrid Therapeutics do?
- Sigrid Therapeutics develops non-pharmaceutical solutions for blood sugar control and weight management using its patented SiPore silica technology, which slows the digestion of carbohydrates and fats in the gut. The company offers medical and consumer metabolic health products aimed at people with prediabetes, diabetes, and obesity.
- Who founded Sigrid Therapeutics?
- Sigrid Therapeutics was founded by Sana Alajmovic.
- Who are Sigrid Therapeutics's investors?
- Sigrid Therapeutics's investors include Joyance Partners, Ataraxia VC.